Digoxin Immune Fab
Orphan Drug Cold Chain RequiredFDA Approved
Description
Digoxin Immune Fab is an antibody fragment used to treat digoxin toxicity. It works by binding to digoxin, preventing it from exerting its effects on the heart.
Indications & Therapeutic Use
Digoxin toxicity
Linked Diseases:
digoxin toxicity
T46.0
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Digoxin Immune Fab
| Generic Name | Digoxin Immune Fab |
| Brands | 1 brand available |
| Active Ingredient | Digoxin antibodies |
| Drug Class | Digoxin toxicity |
| Manufacturer | BTG International |
| Dosage Forms | Lyophilized powder for IV infusion |
| Medical Code | V03AB04 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes